JPH01285193A - Production of d-aspartic acid - Google Patents
Production of d-aspartic acidInfo
- Publication number
- JPH01285193A JPH01285193A JP11355388A JP11355388A JPH01285193A JP H01285193 A JPH01285193 A JP H01285193A JP 11355388 A JP11355388 A JP 11355388A JP 11355388 A JP11355388 A JP 11355388A JP H01285193 A JPH01285193 A JP H01285193A
- Authority
- JP
- Japan
- Prior art keywords
- alanine
- plasmid
- fragment
- acid
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 title claims abstract description 21
- 238000004519 manufacturing process Methods 0.000 title claims description 13
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims abstract description 19
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims abstract description 14
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000011090 malic acid Nutrition 0.000 claims abstract description 12
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims abstract description 10
- 235000004279 alanine Nutrition 0.000 claims abstract description 7
- 229910021529 ammonia Inorganic materials 0.000 claims abstract description 7
- 229940116298 l- malic acid Drugs 0.000 claims abstract description 7
- 108010031025 Alanine Dehydrogenase Proteins 0.000 claims abstract description 6
- 108010041525 Alanine racemase Proteins 0.000 claims abstract description 5
- 230000001268 conjugating effect Effects 0.000 claims abstract description 4
- 108030001081 D-amino-acid transaminases Proteins 0.000 claims abstract 4
- 102000013460 Malate Dehydrogenase Human genes 0.000 claims description 2
- 108010026217 Malate Dehydrogenase Proteins 0.000 claims description 2
- 229940099690 malic acid Drugs 0.000 abstract description 5
- 239000001630 malic acid Substances 0.000 abstract description 5
- 239000000758 substrate Substances 0.000 abstract description 5
- 101710088194 Dehydrogenase Proteins 0.000 abstract 1
- 108090001066 Racemases and epimerases Proteins 0.000 abstract 1
- 102000004879 Racemases and epimerases Human genes 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 60
- 239000013612 plasmid Substances 0.000 description 50
- 239000012634 fragment Substances 0.000 description 43
- 239000000243 solution Substances 0.000 description 41
- 238000000034 method Methods 0.000 description 28
- 102000004190 Enzymes Human genes 0.000 description 23
- 108090000790 Enzymes Proteins 0.000 description 23
- 238000006243 chemical reaction Methods 0.000 description 23
- 229940088598 enzyme Drugs 0.000 description 23
- 230000000694 effects Effects 0.000 description 20
- 239000000872 buffer Substances 0.000 description 17
- 241000588724 Escherichia coli Species 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 14
- 230000029087 digestion Effects 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 238000005119 centrifugation Methods 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 9
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 9
- 229960000723 ampicillin Drugs 0.000 description 9
- 239000002244 precipitate Substances 0.000 description 9
- 108091008146 restriction endonucleases Proteins 0.000 description 9
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 8
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 8
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 8
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 8
- 229920001817 Agar Polymers 0.000 description 7
- 229920000936 Agarose Polymers 0.000 description 7
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 7
- 102000012410 DNA Ligases Human genes 0.000 description 7
- 108010061982 DNA Ligases Proteins 0.000 description 7
- NOQGZXFMHARMLW-UHFFFAOYSA-N Daminozide Chemical compound CN(C)NC(=O)CCC(O)=O NOQGZXFMHARMLW-UHFFFAOYSA-N 0.000 description 7
- 239000008272 agar Substances 0.000 description 7
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 6
- 229960003767 alanine Drugs 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 238000003776 cleavage reaction Methods 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000007017 scission Effects 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- 229940098773 bovine serum albumin Drugs 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 239000008188 pellet Substances 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 3
- 101000774761 Archaeoglobus fulgidus (strain ATCC 49558 / DSM 4304 / JCM 9628 / NBRC 100126 / VC-16) Alanine dehydrogenase Proteins 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 235000011148 calcium chloride Nutrition 0.000 description 3
- 238000012869 ethanol precipitation Methods 0.000 description 3
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 3
- 239000008057 potassium phosphate buffer Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 description 2
- 229930182847 D-glutamic acid Natural products 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000588722 Escherichia Species 0.000 description 2
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229940076788 pyruvate Drugs 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 1
- 239000001715 Ammonium malate Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108010078895 D-Alanine Transaminase Proteins 0.000 description 1
- 101710097070 D-aminoacylase Proteins 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 101710090249 D-hydantoinase Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 241000908656 Vestiaria coccinea Species 0.000 description 1
- WHZRCUIISKRTJL-UHFFFAOYSA-N [2-(6-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl)-2-oxoethyl] hexanoate Chemical compound C1C(F)C2=CC(=O)C=CC2(C)C2C1C1CC(C)C(C(=O)COC(=O)CCCCC)C1(C)CC2O WHZRCUIISKRTJL-UHFFFAOYSA-N 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- KGECWXXIGSTYSQ-UHFFFAOYSA-N ammonium malate Chemical compound [NH4+].[NH4+].[O-]C(=O)C(O)CC([O-])=O KGECWXXIGSTYSQ-UHFFFAOYSA-N 0.000 description 1
- 235000019292 ammonium malate Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229950010030 dl-alanine Drugs 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 150000004715 keto acids Chemical class 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000011536 re-plating Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000035806 respiratory chain Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- BUUPQKDIAURBJP-UHFFFAOYSA-N sulfinic acid Chemical compound OS=O BUUPQKDIAURBJP-UHFFFAOYSA-N 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、抗生物質の修飾剤等として極めて有用な、D
−アスパラギン酸の製造方法に関する。Detailed Description of the Invention (Industrial Field of Application) The present invention provides D
-Regarding a method for producing aspartic acid.
(従来技術および発明が解決しようとする課題)従来、
酵素法によりD−アスパラギン酸を製造する方法として
は、5−置換LダントインにD−ヒダントイナーゼを作
用させる方法(特公昭56−1909号)やN−アセチ
ル−D−アスパラギン酸にD−アミノアシラーゼを作用
させる方法(特公昭53−36035号)などが知られ
ている。(Prior art and problems to be solved by the invention) Conventionally,
Methods for producing D-aspartic acid by enzymatic methods include a method in which D-hydantoinase is allowed to act on 5-substituted L-dantoin (Japanese Patent Publication No. 1909/1983), and a method in which D-aminoacylase is added to N-acetyl-D-aspartic acid. A method of making the agent act (Japanese Patent Publication No. 53-36035) is known.
しかし、これらの方法は高価な基質を使用したり、原理
的に原料の半分しか目的のD−アスパラギン酸に変換で
きないなど、経済的に優れた方法とはいえない。However, these methods cannot be said to be economically superior, as they use expensive substrates and, in principle, only half of the raw material can be converted into the target D-aspartic acid.
また、我々は、上記の問題を解決する方法として、アミ
ノ基供与体り−アミノ酸を再生する酵素系を利用した、
オキサロ酢酸とアミノ基供与体り一アミノ酸からのD−
アミノ酸トランスアミナーゼ(D−アラニンアミノトラ
ンスフェラーゼ;EC2,6,1,21,以下、D−A
TAと示す)の作用によるD−アスパラギン酸の製法を
見出だしく特開昭62−205790号)、さらに研究
を進めている。Furthermore, as a method to solve the above problem, we used an enzyme system that regenerates the amino group donor RI-amino acid.
D- from oxaloacetic acid and amino group donor RI monoamino acid
Amino acid transaminase (D-alanine aminotransferase; EC2,6,1,21, hereinafter referred to as D-A
We have discovered a method for producing D-aspartic acid by the action of TA (denoted as TA) (Japanese Patent Application Laid-Open No. 62-205790), and are currently conducting further research.
(課題を解決するための手段)
本発明者らは、D−ATAを利用し、安価な原料からD
−アスパラギン酸を製造する方法を確立するべく鋭意研
究した結果、アミノ基供与体り−アミノ酸を再生する酵
素系に付随するNADH再生系として、リンゴ酸および
リンゴ酸脱水素酵素(以下、MDIと示す)系を利用す
ると、原料ケト酸であるオキサロ酢酸までもが生成され
、利用できることに着目し、本発明を完成させた。(Means for Solving the Problems) The present inventors utilized D-ATA to obtain D-ATA from inexpensive raw materials.
- As a result of intensive research to establish a method for producing aspartic acid, we discovered that malic acid and malate dehydrogenase (hereinafter referred to as MDI) are an NADH regenerating system that accompanies the amino group donor enzyme system that regenerates amino acids. ) system, even oxaloacetic acid, which is a raw material keto acid, can be produced and utilized, and the present invention was completed.
即ち本発明は、MDH、アラニン脱水素酵素(以下、A
1 aDHと示す)、アラニンラセマーゼ(以下、Al
aRと示す)、およびD−ATAを共役させることによ
り、微量のアラニンおよびNAD+の存在下、し−リン
ゴ酸とアンモニアからD−アスパラギン酸を製造する方
法である。That is, the present invention provides MDH, alanine dehydrogenase (hereinafter referred to as A
1 aDH), alanine racemase (hereinafter referred to as Al
This is a method for producing D-aspartic acid from malic acid and ammonia in the presence of trace amounts of alanine and NAD+ by conjugating D-ATA (denoted as aR) and D-ATA.
本発明は次の第1式に示すことができる。The present invention can be expressed by the following first equation.
第1式
つまり、基質のL−リンゴ酸はMDIの作用によりオキ
サロ酢酸に変換され、このとき同時にNAD+がNAD
Hに還元される。生成したオキサロ酢酸はD−ATAの
作用によりアミノ基供与体であるD−アラニンと反応し
、D−アスパラギン酸とピルビン酸を生成する。生成し
たピルビン酸からAl aDH%A1aRの作用により
D−アラニンが再生され、同時にNADHからNAD+
が再生される。In the first equation, the substrate L-malic acid is converted to oxaloacetate by the action of MDI, and at the same time, NAD+ changes to NAD
It is reduced to H. The generated oxaloacetic acid reacts with D-alanine, which is an amino group donor, by the action of D-ATA to generate D-aspartic acid and pyruvic acid. D-alanine is regenerated from the generated pyruvate by the action of Al aDH%A1aR, and at the same time, NAD+ is converted from NADH.
is played.
本発明に使用されるMDH,A1 aDH,AlaR,
D−ATAはそれらの生産能を有する微生物、植物、動
物などより別個に或いは同時に調製することができ、そ
の起源は特に限定されないが、例えば、MDHは、エシ
ェリヒア・コリ(E 5cherichia coli
)、サーマス−7ラパス(Thernus fIavu
S)等の微生物、豚心筋より得ることができ、また、市
販品を利用することもできる。MDH used in the present invention, A1 aDH, AlaR,
D-ATA can be prepared separately or simultaneously from microorganisms, plants, animals, etc. that have the ability to produce them, and the origin is not particularly limited. For example, MDH is derived from Escherichia coli
), Thernus fIavu
It can be obtained from microorganisms such as S), pig myocardium, and commercially available products can also be used.
AlaDH,AlaRはバチルス属をはじめとする微生
物、植物より得ることができ、具体的には、バチルス・
ステアロサーモフィラス(Bacillus stea
rothermophilus) I F O125
50から得られる酵素を、その安定性、生産性の点で優
れた酵素として挙げるとこができる。AlaDH and AlaR can be obtained from microorganisms and plants including the genus Bacillus.
Bacillus stea
(rothermophilus) I F O125
50 can be cited as an enzyme that is excellent in terms of stability and productivity.
D −A T A’もまた、バチルス属をはじめとする
微生物、植物より得ることができ、具体的には、バチル
ス・エスピーYM−1(微工研菌寄第8057号)より
得られるD−ATA (特開昭61−187786号)
を挙げることができる。D-ATA' can also be obtained from microorganisms and plants including the genus Bacillus, and specifically, D-A' obtained from Bacillus sp. ATA (Unexamined Japanese Patent Publication No. 187786/1986)
can be mentioned.
これらの起源より上記4酵素を調製して本発明の反応に
使用し、光学純度の高いD−アスパラギン酸を得るため
には、その微生物、植物、動物が該酵素以外に生産して
いる酵素のうち、D−アスパラギン酸の光学純度を低下
させる原因となるものを精製によって除去するか、或い
は、阻害剤。In order to prepare the above four enzymes from these sources and use them in the reaction of the present invention to obtain D-aspartic acid with high optical purity, it is necessary to prepare the enzymes produced by the microorganism, plant, or animal in addition to the above enzymes. Among them, substances that cause a decrease in the optical purity of D-aspartic acid are removed by purification, or inhibitors.
熱、pH等に対する感受性の差を利用して失活させる必
要がある0例えば、バチルス・ステアロサーモフィラス
IFO12550由来のA 1 aDHおよびAlaR
をコードする遺伝子と、バチルス・エスピーYM−1株
由来のD−ATAをコードする遺伝子を同時に含有する
プラスミドpICDRT111(特願昭62−1407
07号)でMDIを生産するエシェリヒア・コリを形質
転換すると、その形質転換株エシェリヒア・コリHBI
01 (PICDRTIII)は、上記4酵素を同時に
生産できるので本発明には好適である。For example, A 1 aDH and AlaR derived from Bacillus stearothermophilus IFO12550, which need to be inactivated by taking advantage of differences in sensitivity to heat, pH, etc.
Plasmid pICDRT111 (Japanese Patent Application No. 1407-1981) simultaneously contains the gene encoding D-ATA derived from Bacillus sp. YM-1 strain.
When Escherichia coli that produces MDI is transformed with 07), the transformed strain Escherichia coli HBI
01 (PICDRTIII) is suitable for the present invention because it can simultaneously produce the above four enzymes.
本発明の反応において基質となるし一リンゴ酸は50〜
1000m M、アンモニアはリンゴ酸の2倍量程度、
NAD+は0.1〜10mM、アラニンはD、DL、或
いはL体を0.1〜10mM、 D−ATA、AlaR
,AlaDHおよびMDHはそれぞれ0゜1〜10U
/ ml程度の濃度で添加される。また、補酵素である
ピリドキサール5°−リン酸(以下、PLPと示す)は
必要に応じて1〜100μM程度添加される。Monomalic acid, which serves as a substrate in the reaction of the present invention, has a concentration of 50 to
1000mM, ammonia is about twice the amount of malic acid,
NAD+ is 0.1-10mM, alanine is D, DL, or L-form is 0.1-10mM, D-ATA, AlaR
, AlaDH and MDH are each 0°1~10U
/ml. Further, pyridoxal 5°-phosphate (hereinafter referred to as PLP), which is a coenzyme, is added at about 1 to 100 μM as necessary.
反応温度および反応液のpHは、使用される4酵素の至
適温度および至適PHに合わせて調整されるが、一般に
20〜50℃、pH6〜10の範囲が好ましい、pHの
調整には各種の緩衝液を用いることもできるし、基質の
一つであるアンモニアを用いることもできる。The reaction temperature and pH of the reaction solution are adjusted according to the optimum temperature and optimum pH of the four enzymes used, but generally a range of 20 to 50°C and a pH of 6 to 10 is preferred. A buffer solution can be used, or ammonia, which is one of the substrates, can also be used.
反応は通常4〜48時間行われるが、他の条件に応じて
適当に変えることもできる。The reaction is usually carried out for 4 to 48 hours, but this can be changed appropriately depending on other conditions.
反応液からのD−アスパラギン酸の採取は、例えば、反
応液に終濃度5%(14/V)になるようにトリクoo
酢酸を添加し、Al1berlite IR−120(
H”型)に通し、リンゴ酸、オキプロ酢酸等を素通りさ
せ、吸着したアミノ酸をDowex 1 (酢酸型)に
通し、アラニン等を素通りさせてからD−アスパラギン
酸を2N酢酸で溶出することにより行なうことができる
。To collect D-aspartic acid from the reaction solution, for example, add a trichloride to the reaction solution to give a final concentration of 5% (14/V).
Add acetic acid and add Alberlite IR-120 (
D-aspartic acid is passed through Dowex 1 (acetic acid type), passing through Dowex 1 (acetic acid type), allowing alanine, etc. to pass through, and then eluting D-aspartic acid with 2N acetic acid. be able to.
以下、実施例を以て本発明を説明するが、本発明はこれ
に限定されるものではない。The present invention will be explained below with reference to Examples, but the present invention is not limited thereto.
(実施例)
実施例1
(1)D−ATAをコードする遺伝子を含有するプラス
ミドPICTIIIの創製
バチルス・エスピーYM−1を表−1に示す培地で55
℃、6時間培養した後集菌し、菌体6.Ogを得た。(Example) Example 1 (1) Creation of plasmid PICTIII containing the gene encoding D-ATA Bacillus sp.
After culturing at ℃ for 6 hours, the bacteria were collected and the bacterial cells were collected. Obtained Og.
次に得られた菌体より斎藤−三浦法に従って染色体DN
Aを抽出し、これをHindl(賓酒造製)によって3
時間消化して1〜10K bのDNA断片を得た。Next, the chromosomal DNA was extracted from the obtained bacterial cells according to the Saito-Miura method.
Extract A and use Hindl (manufactured by Hindshuzo) to
DNA fragments of 1 to 10 Kb were obtained by time digestion.
続いて、プラスミドpBR3223μgを旦ind I
[によって完全消化し、これを先に得られた染色体から
のDNA断片と74DNAリガーゼ(賓酒造製)によっ
て連結し、この反応液をエタノール沈澱により濃縮した
。Subsequently, 3223 μg of plasmid pBR3 was added to ind I
This was completely digested with [ and ligated with the previously obtained DNA fragment from the chromosome using 74 DNA ligase (manufactured by Hinshuzo), and the reaction solution was concentrated by ethanol precipitation.
この濃縮液を用いて、マンデルーヒガ(M andel
−Higa )の方法(ジャーナル・オプ・モレキュラ
ー・バイオロジー(J、Mol、B111.) 、 5
3゜159 (197G))によりエシェリヒア・コリ
C600を形質転換した。Using this concentrate, Mandelhiga
-Higa) method (Journal of Molecular Biology (J, Mol, B111.), 5
3°159 (197G)) was used to transform Escherichia coli C600.
形質転換株の中からD−ATAをコードする遺伝子を含
有するプラスミドを有する株を選択するために、形質転
換株を表−2に示す組成の最少培地の寒天上で培養した
。目的の株は窒素源としてD−グルタミン酸資化性を獲
得するため、目的の株のみがこの培地上で生育可能であ
り、生育した株は約100コロニーであった。In order to select a strain having a plasmid containing the gene encoding D-ATA from among the transformed strains, the transformed strains were cultured on agar in a minimal medium having the composition shown in Table 2. Since the target strain acquires the ability to assimilate D-glutamic acid as a nitrogen source, only the target strain could grow on this medium, and the number of colonies that grew was about 100.
次にin 5ituにおけるD−ATA活性を確認す
るため、ラエツ(Raetz)らの方法(プロシーディ
ング・オブ・ナショナル・アカデミ−・オブ・サイエン
ス・オブ・ニーニスニー(Proc、Natl。Next, to confirm D-ATA activity in 5 situ, we used the method of Raetz et al. (Proc. Natl.
Acad、Sci、 USA) 、 72.2274
(1975))を一部改変した以下に示す方法に従って
活性染色を行なっな、即ち、プレート上に生育させた約
100コロニーからフィルター上にレプリカを作成し、
リゾチーム処理(リゾチーム溶液<io■/ml)2m
l中で室温にて30分間)し、余分な水分を除去した後
、1mlの呼吸鎖阻害液(20mM NaN3.10
mMKF、1mM Na HASO4,4mMトリスー
塩酸MWI液(pH7,4))を添加し、2度凍結、融
解し、溶菌した。Acad, Sci, USA), 72.2274
Activity staining was carried out according to the following method, which was partially modified from (1975), that is, replicas were made on a filter from about 100 colonies grown on a plate,
Lysozyme treatment (lysozyme solution <io■/ml) 2m
After removing excess water, add 1 ml of respiratory chain inhibitor solution (20 mM NaN3.10
mMKF, 1mM Na HASO4, 4mM Tris-HCl MWI solution (pH 7,4)) were added, frozen twice, thawed, and lysed.
続いてこれを70℃で20分間処理した後、表−3に示
す反応液を1.5ml添加し、50℃で10分間反応さ
せた。これによってD−ATA活性を有する株は青色を
呈するため、強い青色を呈したコロニーを1株選択した
。この株が含有しているプラスミドをplCTlllと
した。Subsequently, this was treated at 70°C for 20 minutes, and then 1.5 ml of the reaction solution shown in Table 3 was added and reacted at 50°C for 10 minutes. As a result, strains with D-ATA activity exhibit a blue color, and one colony exhibiting a strong blue color was selected. The plasmid contained in this strain was designated as plCTlll.
次に、plCTlllを才力の方法(ジャーナル オブ
バクテリオロジー(J 、 Bacteriol、
)、L猥−,916(1978))に従い単離し、ps
ユI、堕RI、Ban1l[、Hindlf[,5al
I(賓酒造製)ニよりマツピングを行なった。plcT
lllの制限酵素切断地図を第1図に示す。Next, plCTllll is a method of genius (Journal of Bacteriology (J, Bacteriol,
), L.B., 916 (1978)) and ps
Yu I, Fallen RI, Ban1l [, Hindlf [, 5al
I (manufactured by Hinshuzo) was mapped. plcT
The restriction enzyme cleavage map of 1ll is shown in FIG.
表 −1
ポリペプトン 0.5 %酵母エキス
0.25%肉エキス
0.2 %グリセロール 0.
5 %KH2PO40,2%
に2HPO40,2%
NaC10,05%
MgSO4・7H200,01%
DL−アラニン 0.3 %し一グルタ
ミン酸 0.2 %ビオチン
4 X 1G’%00m1
PH7,2
表 −2
チアミン 1 ■L−ロイ
シン 10 NL−スレオニン
20 昭Mg50 ・7H20
50■
MnCl2−4H205ratz
FeSO4・7H200,25n(I
CaC120,5rst
酵母エキス 0.5 ■リン酸カ
リウム緩衝液(pt17.2) 20 m1
olアンピシリン 25 ■D−
グルタミン酸 4gピルビン酸
1gJ
表 −3
トリス−塩酸緩衝液(pH8,3) 1’50
μmolD−システィンスルフィン酸 1.5μm
olα−ケトグルタル酸 15 μ1oI
PLP 75 nmo
lフェナジンメトサルフェイト 150 nmol
ニトロブルーテトラゾリウム 900 nmol(
2)P ICTl 11のサブクローニングPICTI
IIをエイチ、シー、バーンポイン・アンド・ジエイ、
ドーリ−(H,C,Birnboin and J 、
Doly)の方法(ヌクレイツク アシッズ リサー
チ(NIJCreiCACidS Re5earch
’) 。Table-1 Polypeptone 0.5% yeast extract 0.25% meat extract
0.2% glycerol 0.
5% KH2PO40.2% to 2HPO40.2% NaC10.05% MgSO4.7H200.01% DL-alanine 0.3% monoglutamic acid 0.2% biotin
4
50 ■ MnCl2-4H205ratz FeSO4・7H200,25n (I CaC120,5rst Yeast extract 0.5 ■ Potassium phosphate buffer (pt17.2) 20 ml
ol ampicillin 25 ■D-
Glutamic acid 4g Pyruvate
1gJ Table-3 Tris-HCl buffer (pH 8,3) 1'50
μmol D-cystine sulfinic acid 1.5μm
olα-ketoglutaric acid 15μ1oI
PLP 75 nmo
l Phenazine methosulfate 150 nmol
Nitro blue tetrazolium 900 nmol (
2) Subcloning of PICTl 11 PICTI
II to H, C, Burnpoint & G.A.
Dolly (H, C, Birnboin and J,
Doly) method (NIJCreiCACidS Re5earch)
').
ヱ、 1513(1979) )に従い単離し、l勉R
I(賓酒造製)で完全消化し、アガロースゲル電気泳動
後、約1.7Kbの1臼RI−堕RI断片を含むゲルを
切り出し、DNA断片を溶出した。E., 1513 (1979)) and isolated according to I.R.
After complete digestion with I (manufactured by Hinshuzo) and agarose gel electrophoresis, the gel containing the approximately 1.7 Kb 1 molar RI-fallen RI fragment was cut out and the DNA fragment was eluted.
プラスミドpUc18をEC0RIで完全消化し、これ
を精製したpIcT112のL並RI−E印RI断片と
T4DNAリガーゼにより連結し、この連結されたプラ
スミドでエシェリヒア・コリJM103を形質転換し、
形質転換株をイソプロピル−1−チオーβ−D−ガラク
トサイド、5−クロロ−4−ブロモ−3−インドリル−
β−D−ガラクトース及びアンピシリンを含むし培地(
1%ポリペプトン、0.5%酵母エキス、0.5%Na
C1,0,1%グルコース;pH7,2)上で培養した
。Plasmid pUc18 was completely digested with EC0RI, and this was ligated with the purified L parallel RI-E mark RI fragment of pIcT112 using T4 DNA ligase, and Escherichia coli JM103 was transformed with this ligated plasmid.
The transformed strain was treated with isopropyl-1-thio β-D-galactoside, 5-chloro-4-bromo-3-indolyl-
Medium containing β-D-galactose and ampicillin (
1% polypeptone, 0.5% yeast extract, 0.5% Na
C1,0,1% glucose; pH 7,2).
ここでD−ATA活性を有する株は青色を呈さないので
青色でない株を選択した。この株が含有しているプラス
ミドをpIc7113とした。Here, since strains having D-ATA activity do not exhibit blue color, strains that were not blue were selected. The plasmid contained in this strain was designated pIc7113.
次に、pIcT113を才力の方法に従い単離し、Ps
tI 、EcoRI 、 Ban1ll、Hindl[
,5atIによりマツピングを行なった。pIc711
3の制限酵素切断地図を第2図に示す。Next, pIcT113 was isolated according to the method of Saito, and Ps
tI, EcoRI, Ban1ll, Hindl [
, 5atI was used for mapping. pIc711
The restriction enzyme cleavage map of No. 3 is shown in FIG.
PICT113をエイチ、シー、バーンポイン・アンド
・ジェイ、ドーリ−の方法に従い単離した。PICT113 was isolated according to the method of H.C., Burnpoint and J.Dawley.
(3)AlaDHをコードする遺伝子を含有するプラス
ミドpICD112の創製
特開昭60−180590号公報4〜5頁に記載の方法
(こ従い、該時開公報でいうところのpICR301を
創製しく我々はこれをpIcD112と名付けた)、こ
れによってエシェリヒア・コリC600を形質転換した
。(3) Creation of plasmid pICD112 containing the gene encoding AlaDH The method described in JP-A-60-180590, pages 4-5 (Following this, we created pICR301 as referred to in the publication). (named pIcD112) was used to transform Escherichia coli C600.
次に、形質転換株からplcD112をエイチ。Next, extract plcD112 from the transformed strain.
シー、バーンポイン・アンド・ジエイ、ドーリ−の方法
に従い単離した。It was isolated according to the method of C., Burnpoint & G.A., Doley.
<4)AlaRをコードする遺伝子を含有するプラスミ
ドpIcR113の創製
バイオゲミストリ−(B iochemistry )
、 25゜3268−3274 、 (1986)に
記載の方法に従い、pICR401を創製しく我々はこ
れをplcR113と名付けた)、これによってエシェ
リヒア・コリc eooを形質転換した。<4) Creation of plasmid pIcR113 containing the gene encoding AlaR Biochemistry
pICR401 was created (we named it plcR113) and transformed into Escherichia coli ceoo according to the method described in , 25° 3268-3274, (1986).
pIcR113をエイチ、シー、バーンポイン・アンド
・ジエイ、ドーリ−の方法に従い単離した。pIcR113 was isolated according to the method of H.C., Burnpoint & G.D., Doley.
(5)プラスミドplcT113のEcoRI−3ac
I断片の調製
(2)で得られたプラスミドplcT11330μrt
sac 1300 Uを含む5acI用MWI液(10
mM トリス−塩酸緩衝液(pH8,0) 、7mM
MgCl 、7mM2−メルカプトエタノ−ル(
2−ME)、0.01%牛血清アルブミン(BSA))
400μオ中で37℃で5時間反応させ消化した後、5
M NaCl3μj、冷エタノール850μmを添加
し、遠心分離によりDNAをエタノール沈殿として回収
した0回収したDNAベレットを20μjのTEに溶解
し、EcoR1150Uを含むEcoRI用緩衝液(5
0mM トリス−塩酸緩衝液(1)H7,5) 、7
mM MgCI 、100 mMNaC1,7mM
2−ME、0.01%BSA)400μm中で5時
間反応させ消化した後、800μmの冷エタノールを添
加し遠心分離によりDNAをエタノール沈殿として回収
した。(5) EcoRI-3ac of plasmid plcT113
Plasmid plcT11330μrt obtained in I fragment preparation (2)
MWI solution for 5acI containing 1300 U of sac (10
mM Tris-HCl buffer (pH 8,0), 7mM
MgCl, 7mM 2-mercaptoethanol (
2-ME), 0.01% bovine serum albumin (BSA))
After reacting and digesting in 400 µO at 37°C for 5 hours,
Add 3 μj of M NaCl and 850 μm of cold ethanol, and collect the DNA as ethanol precipitate by centrifugation. The recovered DNA pellet was dissolved in 20 μj of TE, and EcoRI buffer containing 1150 U of EcoR (5
0mM Tris-HCl buffer (1) H7,5), 7
mM MgCI, 100mM NaCl, 7mM
After reaction and digestion in 400 μm (2-ME, 0.01% BSA) for 5 hours, 800 μm cold ethanol was added and the DNA was recovered as an ethanol precipitate by centrifugation.
(6)プラスミドpIcD112のEcoRV−Hln
dll[断片の調製
(3)で得られたpICD112 40μgを制° 限
酵素H1ndI[(宝酒造社製) 40Uを含む辻1旦
dl用緩衝液(10nH)リス−塩酸緩衝液(+)H7
゜5)、7mM MgCI 、60mMNa’CI
) 30Gμm中で3時間反応させ、5MNaC13
μj、冷エタノール650μ」を添加し、遠心分離によ
りDNAをエタノール沈殿として回収した0回収したD
NAベレットを20μmのTHに溶解し、40Uの制限
酵素EcoRV(宝酒造社製)を含む1旦旦RV用緩衝
液(10mMトリス−塩酸緩衝液(pH7,5) 、7
mMMgCI 、150 mM NaCI、71N
2−ME、0.01%BSA)300μm中で37
℃、3時間反応させ、冷エタノール600μmを添加し
遠心分離することにより、DNAをエタノール沈殿とし
て回収した。このDNAを20μオのTF、に溶解し0
.7%LM P (low meltino poin
t )アガロース(Bethesda Re5ear
ch Laboratories製)を用いて4℃にお
いて100 Vで5〜6時間電気泳動を行い、A1 a
DHをコードする遺伝子を含有する1、4KbのHi
ndl−EcoRV断片を分離し、この断片を含むアガ
ロースを切り取り、5倍容量のTEを加え65℃で5分
間加熱してアガロースを溶解した。この溶液を、フェノ
ール抽出、フェノール−クロロホルム<1:1)抽出、
クロロホルム抽出を各1回行った後、エタノール沈殿と
してDNA断片を回収した。このDNA断片を少量のT
Eに溶解し、逆相液体クロマトグラフィー (NENS
ORB”20、デュポン製)により精製し、50%/タ
ノールで溶出し、乾固した後20μオのTHに溶解し、
プラスミドplcD112の精製EcoRV−H1nd
l!7r片を調製しな。(6) EcoRV-Hln of plasmid pIcD112
dll [40 μg of pICD112 obtained in fragment preparation (3) was added to Tsuji Ichidan dl buffer (10 nH) containing 40 U of restriction enzyme H1ndI [(manufactured by Takara Shuzo Co., Ltd.)] Lis-hydrochloric acid buffer (+) H7
゜5), 7mM MgCI, 60mM Na'CI
) Reacted for 3 hours in 30Gμm, 5M NaC13
μj, 650μ of cold ethanol was added, and the DNA was recovered as an ethanol precipitate by centrifugation.
The NA pellet was dissolved in 20 μm of TH, and then mixed with RV buffer (10 mM Tris-HCl buffer (pH 7,5), 7
mM MgCI, 150 mM NaCI, 71N
2-ME, 0.01% BSA) 37 in 300 μm
The reaction mixture was incubated at ℃ for 3 hours, and the DNA was recovered as an ethanol precipitate by adding 600 μm of cold ethanol and centrifuging. This DNA was dissolved in 20 μιι TF.
.. 7%LM P (low meltino point
t) Agarose (Bethesda Re5ear
electrophoresis was performed at 100 V for 5 to 6 hours at 4°C using a
1.4 Kb Hi containing the gene encoding DH
The ndl-EcoRV fragment was separated, the agarose containing this fragment was cut out, 5 times the volume of TE was added, and the agarose was dissolved by heating at 65° C. for 5 minutes. This solution was extracted with phenol extraction, phenol-chloroform <1:1) extraction,
After performing chloroform extraction once each, DNA fragments were recovered as ethanol precipitation. Add this DNA fragment to a small amount of T.
Dissolved in E and subjected to reverse phase liquid chromatography (NENS
ORB"20, manufactured by DuPont), eluted with 50% ethanol, dried, and then dissolved in 20 μO TH.
Purification of plasmid plcD112 EcoRV-H1nd
l! Prepare 7r pieces.
(7)プラスミドpIcR113のEcoRI−3ac
I断片の調製
(4)で得られたplcR11340μgを制限酵素5
acI(宝酒造社製) 300 Uを含む且3cl用緩
衝液400μm中で5時間反応させ消化した後、5M
NaCl3μj、冷エタノール850μmを添加し、
遠心分離によりDNAをエタノール沈殿として回収した
0回収したDNAベレットを20μmのTHに溶解し、
150 Uの制限酵素EcoRI (宝酒造社製)を含
むEcoRI用IIWI液400μオ中で37℃、5時
間反応させ、冷エタノール800μmを添加することに
より、DNAをエタノール沈殿として回収した。このD
NAを20μmのTHに溶解し、0.7%LMPアガロ
ースを用いて4℃において100Vで5〜6時間電気泳
動を行い、AlaRをコードする遺伝子を有する1、9
KbのEcoRI−3ac I断片を分離し、この断片
を含むアガロースを切り取り、5倍容量のTEを加え6
5℃で5分間加熱してアガロースを溶解しな、この溶液
を、フェノール抽出、フェノール−クロロホルム(1:
1)抽出、クロロホルム抽出を各1回行いエタノール沈
殿としてDNA断片を回収した。このDNA断片を少量
のTHに溶解し、逆相液体クロマトグラフィーにより精
製し、50%メタノールで溶出した後、乾固してプラス
ミドPICR113の精製EcoRI−8ac I断片
を調製した。(7) EcoRI-3ac of plasmid pIcR113
40 μg of plcR11 obtained in I fragment preparation (4) was treated with restriction enzyme 5
After reaction and digestion for 5 hours in 400 μm of 3 cl buffer containing 300 U of acI (manufactured by Takara Shuzo Co., Ltd.), 5M
Add 3 μm of NaCl and 850 μm of cold ethanol,
DNA was recovered as ethanol precipitate by centrifugation. The recovered DNA pellet was dissolved in 20 μm TH,
The DNA was reacted at 37° C. for 5 hours in 400 μm of IIWI solution for EcoRI containing 150 U of restriction enzyme EcoRI (manufactured by Takara Shuzo Co., Ltd.), and 800 μm of cold ethanol was added to recover the DNA as an ethanol precipitate. This D
NA was dissolved in 20 μ m TH and electrophoresed using 0.7% LMP agarose at 100 V for 5 to 6 hours at 4°C.
The Kb EcoRI-3ac I fragment was isolated, the agarose containing this fragment was cut out, and 5 times the volume of TE was added.
The agarose was dissolved by heating at 5°C for 5 minutes, and the solution was extracted with phenol and phenol-chloroform (1:
1) Extraction and chloroform extraction were performed once each, and DNA fragments were recovered as ethanol precipitation. This DNA fragment was dissolved in a small amount of TH, purified by reverse phase liquid chromatography, eluted with 50% methanol, and dried to prepare a purified EcoRI-8ac I fragment of plasmid PICR113.
(8)プラスミドplcT113のEcoRI−3ac
I断片と1ラスミドpIcR113のムoRI−8a
c I断片の連結
(5)で調製したPICT113のEcoRI。(8) EcoRI-3ac of plasmid plcT113
MuoRI-8a of I fragment and 1 lasmid pIcR113
c EcoRI of PICT113 prepared in I fragment ligation (5).
Sac I消化物を20μmのTHに溶解し、(7)で
調製したpIcR113のBcoRI、5acI消化物
を20μmのTEに溶解した。pIcT113のEco
RI−8ac I断片溶液1.uj、pICR113の
EcoRI−3ac Iの断片溶液8μmをT4DNA
リガーゼ700Uを含むT4DNAリガーゼ用緩衝液(
66m M トリス−塩酸1街液(DH7,6)、6.
6mM MgCl 、10mMジチオスライトール
(DTT) 、1nHATP)20μ」中で一晩反応さ
せDNA断片を連結しな。The Sac I digest was dissolved in 20 μm TH, and the BcoRI, 5ac I digest of pIcR113 prepared in (7) was dissolved in 20 μm TE. Eco of pIcT113
RI-8ac I fragment solution 1. uj, 8 μm of EcoRI-3ac I fragment solution of pICR113 was added to T4 DNA.
T4 DNA ligase buffer containing 700U of ligase (
66mM Tris-hydrochloric acid solution (DH7,6), 6.
The DNA fragments were ligated by reacting overnight in 20μ of 6mM MgCl, 10mM dithiothreitol (DTT), 1nHATP.
(9)(8)で連結したDNAによるエシェリヒア・コ
リHBIOIの形質転換
エシェリヒア・コリHBIOIを100m1のYT培地
(ポリペプトン1t、酵母エキス0.!zr、NaC1
G、5 g/lGG ml、 pH7,2)で2〜3時
間培養し、遠心分離により菌体を回収して冷100 m
M MgCl2で洗浄後、冷100mM CaCl
2に懸濁し1時間氷上に放!した0次に遠心分離により
上滑を除去後、冷100 mM CaC125mlに
再懸濁し、コンピテントセルとした。(9) Transformation of Escherichia coli HBOI with the DNA ligated in (8) Escherichia coli HBOI was transformed into 100 ml of YT medium (1 t of polypeptone, 0.!zr of yeast extract, 1 ml of NaCl).
G, 5 g/l GG ml, pH 7,2) for 2 to 3 hours, collect the bacterial cells by centrifugation, and place in a cold 100 m
After washing with M MgCl2, cold 100mM CaCl
Suspend in 2 and leave on ice for 1 hour! After removing the supernatant by centrifugation, the cells were resuspended in 125 ml of cold 100 mM CaC to obtain competent cells.
次に(8)で得られた連結したDNAの溶液10μmと
コンピテントセル懸濁液200μmを0℃で混合し、時
々撹拌しながら氷上に60分間放置した後、42℃で2
分間放置し、氷上で急冷した0次にこの懸濁液に1ml
のYT培地を加え、37℃で1時間振盪培養した後、ア
ンピシリン含有(50μg/m1)YT−寒天培地(寒
天20t/j)にル−ティングし、37℃で一晩培養し
、形成したコロニーをアンピシリン含有YT−寒天培地
に再ブレーティングし、37℃で一晩培養して得られた
コロニーを形質転換株とした。Next, 10 μm of the ligated DNA solution obtained in (8) and 200 μm of the competent cell suspension were mixed at 0°C, left on ice for 60 minutes with occasional stirring, and then heated at 42°C for 2 hours.
Let it stand for a minute and then quickly cool it on ice. Then add 1 ml of this suspension.
YT medium was added and cultured with shaking at 37°C for 1 hour, then routed to ampicillin-containing (50 μg/ml) YT-agar medium (agar 20t/j), and cultured overnight at 37°C, forming colonies. The cells were replated onto YT-agar medium containing ampicillin, and the colonies obtained by culturing at 37° C. overnight were used as transformed strains.
(10)目的とするプラスミドを保有する形質転換株の
選択
(9)で得られた15個の形質転換株より10株をアン
ピシリン含有(100μg/m1)YT培地5mlで一
晩培養し、該株から小スケールで各1ラスミドを単離し
た。これらのプラスミドを(5)の方法に従いEcoR
IおよびSac Iで消化したところ、全ての1ラスミ
ドが、それぞれ1ケ所ずつ切られて約4.5Kbの単一
なバンドを生じた。(10) Selection of transformants harboring the desired plasmid Ten of the 15 transformants obtained in (9) were cultured overnight in 5 ml of YT medium containing ampicillin (100 μg/ml). One lasmid of each was isolated on a small scale from. These plasmids were converted into EcoR according to method (5).
When digested with Sac I and Sac I, all 1 lasmids were cut at one point each, resulting in a single band of approximately 4.5 Kb.
また、EcoRI、Sac Iのダブル消化により、約
2.7Kbと約1.9Kbの2本のバンドを生じたこと
より、すべてのプラスミドが、ベクターpUC18由来
の部分であるplcT113のEc。Furthermore, double digestion with EcoRI and Sac I produced two bands of approximately 2.7 Kb and approximately 1.9 Kb, indicating that all plasmids were Ec of plcT113, which is derived from the vector pUC18.
R1−3acI断片とAlaRをコードする遺伝子を有
するpIcR113のEcoRI−3acI断片が1つ
ずつ結合したものであることがわかった。これらの1ラ
スミドをpIcR114とした。It was found that one R1-3acI fragment and one EcoRI-3acI fragment of pIcR113 containing the gene encoding AlaR were fused. One of these lasmids was designated pIcR114.
(11)プラスミドplcT113のEcoRI−Ec
oRI断片の調製
(2)で得られたplCT113 40utを旦coR
11sOUを含むEcoRI用緩衝液400μm中で3
7℃、5時間反応させ消化した後、冷エタノール800
μ」添加し遠心分離によりエタノール沈殿として回収し
な、このDNAを20μ」のTHに溶解し、(9)と同
様にしてLMPアガロース電気泳動により分離後、D−
ATAをコードする遺伝子を有する約1.7KbのDN
A断片を切り出し、(7)と同様にして精製し、20μ
mのTEに溶解してプラスミドpIcT113のEco
RI−EcoRI断片溶液を得た。(11) EcoRI-Ec of plasmid plcT113
40 ut of plCT113 obtained in preparation of oRI fragment (2) was first coR
3 in 400 μm of EcoRI buffer containing 11 sOU.
After reacting and digesting at 7°C for 5 hours, add cold ethanol 800
This DNA was dissolved in 20 μ'' of TH and separated by LMP agarose electrophoresis in the same manner as in (9).
Approximately 1.7 Kb DNA containing the gene encoding ATA
The A fragment was excised and purified in the same manner as in (7), and 20μ
Eco of plasmid pIcT113 was dissolved in TE of m.
A RI-EcoRI fragment solution was obtained.
(12)プラスミドplcR114のEcoRIによる
消化
(10)で調製したpIcR114の一部(約4ug)
を、IOUのEcoRIを含むBcoRI用wIw液5
0μm中で37℃、5時間反応させ消化した後、200
μmの冷エタノールを添加し、遠心分離によりエタノー
ル沈殿として回収し、10μmのTEに溶解してプラス
ミドplcR114のF、c旦RI消化物溶液を得た。(12) A portion of pIcR114 (approximately 4 ug) prepared by digestion of plasmid plcR114 with EcoRI (10)
, wIw liquid 5 for BcoRI containing IOU of EcoRI
After reacting and digesting in 0 μm at 37°C for 5 hours,
μm of cold ethanol was added, centrifuged to collect as ethanol precipitate, and dissolved in 10 μm of TE to obtain a solution of F, c and RI digests of plasmid plcR114.
(13)プラスミドpIcT113のEcoRI−F、
coRI断片と、plCR114のBcoRI消化物と
の連結
(11)で調製したプラスミドpICT113のEco
RI−EcoRI断片溶液8μオと、(12)で調製し
たplcR114のEcoRI消化物溶液0.5μオと
をT4DNAリガーゼ700 Uを含むT4DNAリガ
ーゼ用緩衝液20μm中で、16℃−晩反応させDNA
IJi片を連結した。(13) EcoRI-F of plasmid pIcT113,
Eco of plasmid pICT113 prepared by ligating the coRI fragment with the BcoRI digest of plCR114 (11)
8 µm of the RI-EcoRI fragment solution and 0.5 µm of the plcR114 EcoRI digest solution prepared in (12) were reacted at 16°C overnight in 20 µm of T4 DNA ligase buffer containing 700 U of T4 DNA ligase.
The IJi pieces were ligated.
(14) (13)で連結したDNAによるエシェリ
ヒア コリ HBIOIの形質転換
(9)と同様にして調製したコンピテントセル2GGμ
mと(13)で連結したDNAを含む反応液10μmと
を混合し、(9)と同様にして形質転換株を得た。(14) Transformation of Escherichia coli HBIOI with the DNA ligated in (13) Competent cells 2GGμ prepared in the same manner as in (9)
m and 10 μm of the reaction solution containing the DNA linked in (13) were mixed, and a transformed strain was obtained in the same manner as in (9).
(15)D−ATA活性を有する形質転換株の選択(1
4)で得られた約2000個の形質転換株のうち168
個のコロニーを500μオの緩衝漆工(10mMリン酸
カリウム緩衝液(pH7,2) 、0.01%2−ME
、50μMピリドキサールー5°−リン酸(PLP))
に懸濁し、30秒間超音波破砕したものを酵素液として
D−ATA活性を測定しな。(15) Selection of transformed strains with D-ATA activity (1
168 out of approximately 2000 transformed strains obtained in 4)
Buffered lacquer (10mM potassium phosphate buffer (pH 7.2), 0.01% 2-ME
, 50 μM pyridoxal-5°-phosphate (PLP))
D-ATA activity was measured using the enzyme solution that was suspended in water and disrupted by ultrasonication for 30 seconds.
−D−ATA活性の測定方法−
トリス−塩vI緩衝液(t)H8,1) 50.tzm
o 1 、PLP50nmo 1 、a−ケトグルタ
ル酸10μmol、D−アラニン25μmol、乳酸脱
水素酵素(LDH,ベーリンガーマンハイム山之内製)
5U、NADHo、2μmol及び酵素を含む1mlの
反応液を50℃でキュベツト中で反応させ、NADHの
減少に由来する340nmの吸光度の減少を測定した。-Measurement method of D-ATA activity- Tris-salt vI buffer (t)H8,1) 50. tzm
o 1 , PLP 50 nmo 1 , a-ketoglutaric acid 10 μmol, D-alanine 25 μmol, lactate dehydrogenase (LDH, manufactured by Boehringer Mannheim Yamanouchi)
A 1 ml reaction solution containing 5 U, NADHo, 2 μmol, and enzyme was reacted in a cuvette at 50° C., and the decrease in absorbance at 340 nm due to the decrease in NADH was measured.
尚IUはこの条件下1分間に1μmolのNADHの減
少を触媒する酵素量とした。上記方法に従って168個
のコロニーのD−ATA活性を測定した結果、2つのコ
ロニーにD−ATA活性が認められた。Note that IU was defined as the amount of enzyme that catalyzes the reduction of 1 μmol of NADH in 1 minute under these conditions. As a result of measuring the D-ATA activity of 168 colonies according to the above method, D-ATA activity was observed in two colonies.
(16)D−ATA活性保持株の1ラスミドの確認(1
5)で選択した2株から小スケールでプラスミドを単離
した。これらのプラスミドを、5acIで消化したとこ
ろ約6.2Kbの単一のバンドを生じ、EcoRIで消
化したところpIcR114のEcoRI消化物と同じ
約4.5KbのバンドおよびpIcT113のEcoR
I−EcoRI断片と同じ約1.7Kbのバンドを生じ
た。また1且Kbのバンド、pIcR114のEcoR
I−旦acl断片と同じ約1.9Kbのバンドおよびp
I2.7Kbのバンドを生じたことから、これらのプラ
スミドは、pIcR114のEcoRI消化物にpIc
T113のEcoRI−EcoRI断片が結合したもの
であることがわかった。(16) Confirmation of 1 lasmid in a strain retaining D-ATA activity (1
Plasmids were isolated on a small scale from the two strains selected in 5). Digestion of these plasmids with 5acI resulted in a single band of approximately 6.2 Kb, and digestion with EcoRI resulted in a band of approximately 4.5 Kb, the same as the EcoRI digest of pIcR114, and the EcoR of pIcT113.
A band of approximately 1.7 Kb, identical to the I-EcoRI fragment, was generated. Also, a 1 Kb band, EcoR of pIcR114.
The same approximately 1.9 Kb band as the I-dan acl fragment and the p
Since these plasmids produced a 2.7 Kb band, these plasmids were added to the EcoRI digest of pIcR114.
It was found that the EcoRI-EcoRI fragment of T113 was combined.
これらのプラスミドをp ICRTI 11とした。These plasmids were named pICRTI11.
よって、得られたプラスミドplcRT111はAla
Rをコードする遺伝子と、D−ATAをコードする遺伝
子とを同時に有するプラスミドである。Therefore, the obtained plasmid plcRT111 is Ala
This is a plasmid that simultaneously contains a gene encoding R and a gene encoding D-ATA.
(17)プラスミドpIcRT111の調製前述した方
法で、pIcRTlllにより形質転換されたエシェリ
ヒア・3988101株から、精製p ICRTI 1
1を調製した。(17) Preparation of plasmid pIcRT111 Purified pICRTI1 was purified from Escherichia 3988101 strain transformed with pIcRTll by the method described above.
1 was prepared.
(18)プラスミドpIcRT111のHlodl[[
−3maI断片の調製
プラスミドpIcRT111 5μtをSmaI20U
(賓酒造製)を含むSmaI用HWI液(10mM)リ
ス−塩酸緩衝液1pH8、O) 、7mMMgC12,
20mM KG 1 、7mM 2−ME O,0
1%BSA)50μ」中で37℃で5時間反応させ消化
した後、5M NaC11μオ、冷エタノール100
μ」を添加し、遠心分離によりDNAをエタノール沈殿
として回収した。(18) Hlodl of plasmid pIcRT111 [[
- Preparation of 3maI fragment 5 μt of plasmid pIcRT111 and 20U of SmaI
HWI solution for SmaI (10mM) containing (manufactured by Hinshuzo) Lis-hydrochloric acid buffer 1pH8, O), 7mM MgC12,
20mM KG1, 7mM 2-MEO,0
After reaction and digestion at 37°C for 5 hours in 50 μl of 1% BSA, 11 μl of 5M NaC and 100 μl of cold ethanol.
μ'' was added and the DNA was recovered as an ethanol precipitate by centrifugation.
回収したDNAベレットを20μmのTHに溶解し、H
lndl[[20Uを含むH1ndllI用緩衝液50
μm中で5時間反応させ消化した後、5M NaC1
0,5μm、エタノール100μオを添加し遠心分離に
よりDNAをエタノール沈殿として回収した。The recovered DNA pellet was dissolved in 20 μm TH and
H1ndllI buffer containing 20U of lndl[[50
After reaction and digestion in μm for 5 hours, 5M NaCl
0.5 μm and 100 μm of ethanol were added and centrifuged to recover the DNA as an ethanol precipitate.
回収したDNAペレットを20μmのTBに溶解し、p
IcRTlllのHl ndl[−3maI断片溶液と
した。The recovered DNA pellet was dissolved in 20 μm TB and p
It was made into a Hl ndl [-3maI fragment solution of IcRTlll.
(19)プラスミドpIcD112のHindl−Ec
oRV断片とプラスミドp ICRTI 11のHi
ndlll−3maI断片の連結(6)で調製しfip
IcD112のHlndl[−EcoRV断片溶液IQ
μjと(18)で調製したpIcRTlllのHlnd
ll[−3maI断片溶液10μmをT4DNAリガー
ゼ700Uを含むT4DNAリガーゼ用M衝液30μオ
中で一晩反応させ、DNA断片を連結した。(19) Hindl-Ec of plasmid pIcD112
oRV fragment and plasmid p ICRTI 11 Hi
prepared by ligation (6) of the ndlll-3maI fragment and fip
Hlndl of IcD112[-EcoRV fragment solution IQ
μj and Hlnd of pIcRTlll prepared in (18)
ll[-3maI fragment solution (10 μm) was reacted overnight in 30 μm of T4 DNA ligase M solution containing 700 U of T4 DNA ligase to ligate the DNA fragments.
(20) (19)で連結したDNAによるエシェリ
ヒア・コリHBIOIの形質転換
エシェリヒア・コリHBIOIを100m1のYT培地
で3時間培養し、遠心分離により菌体を回収した0次に
、菌体を冷100 m M M g CI 2で洗浄
後、冷100mM CaCl2に懸濁し、1時間氷上
に放1した0次に遠心分離により上清を除去後、冷10
0 m M Ca C125mlに再懸濁し、コンピ
テントセルとした。(20) Transformation of Escherichia coli HBOI with the DNA ligated in (19) Escherichia coli HBOI was cultured in 100 ml of YT medium for 3 hours, and the bacterial cells were collected by centrifugation. After washing with mM Mg CI2, suspend in cold 100mM CaCl2 and leave on ice for 1 hour.Then, remove the supernatant by centrifugation, and incubate in cold 100mM CaCl2.
The cells were resuspended in 125 ml of 0 m M Ca C to form competent cells.
(19)で得られた連結したDNA溶液5μmとコンピ
テントセル懸濁液200μmを0℃で混合し、時々攪拌
しながら氷上に60分間装いた後、42℃で2分間放置
し、氷上で急冷した0次にこの懸濁液に1 mlのYT
培地を加え、37℃で1時間振盪培養した後、アンピシ
リン含有(50μg / ml ) Y T −寒天培
地(寒天20t/Jl)にブレーティングし、37℃で
一晩培養し、形成したコロニーをアンピシリン含有YT
−寒天培地に再ブレーティングし、37℃で一晩培養し
て得られたコロニーを形質転換株とした。5 μm of the ligated DNA solution obtained in (19) and 200 μm of the competent cell suspension were mixed at 0°C, placed on ice for 60 minutes with occasional stirring, left at 42°C for 2 minutes, and rapidly cooled on ice. Then add 1 ml of YT to this suspension.
After adding the medium and incubating with shaking at 37°C for 1 hour, it was plated onto ampicillin-containing (50 μg/ml) YT-agar medium (20 t/Jl of agar), cultured overnight at 37°C, and the formed colonies were incubated with ampicillin. Contains YT
- The colonies obtained by re-plating on agar medium and culturing overnight at 37°C were used as transformed strains.
(21)目的とするプラスミドを保有する形質転換株の
選択
1 ) A 1 aDHの活性染色
フィルター上に(20)で得られた形質転換株のレプリ
カを作成し、プロシーディング・オブ・ナチュラル・ア
カデミ−・オブ・サイエンス・オブ・ニーニスニー、
72.2274−2278(1975)に記載の方法に
従い、50m Mグリシン−KCI −KOHW衝液[
pH9,0) 、50mM L−アラニン、1.3
mMNAD” 、0.128 mMフェナジンメトサル
フェート(PMS) 、0.48mMニトロブルーテト
ラゾリウム(NBT)を含む反応液2mlと反応させ、
゛発色によりA1aDH活性を有する形質転換株を見分
け、分離した。(21) Selection of a transformed strain carrying the desired plasmid 1) Create a replica of the transformed strain obtained in (20) on an A1aDH activity staining filter, and place it at the Proceedings of the Natural Academy of Sciences. -・Science of Ninisny,
72.2274-2278 (1975), a 50 m M glycine-KCI-KOHW solution [
pH 9,0), 50mM L-alanine, 1.3
2 ml of a reaction solution containing 0.128 mM phenazine methosulfate (PMS) and 0.48 mM nitro blue tetrazolium (NBT).
゛Transformed strains having A1aDH activity were identified and isolated by color development.
2)プラスミドの確認
1)で得られたAl aDH活性保有株のうちの6株を
アンピシリン含有(100μt / ml ) Y T
培地5 mlで一晩培養し、小スケールで各プラスミド
を単離した。2) Confirmation of plasmid Six of the strains possessing Al aDH activity obtained in 1) were treated with ampicillin-containing (100 μt/ml) YT.
Each plasmid was isolated on a small scale by culturing overnight in 5 ml of medium.
これらのプラスミドを(6)の方法に従いHindll
[で消化したところ、全てのプラスミドが、各1ケ所切
られ約7.6Kbの単一なバンドを生じた。These plasmids were transferred to Hindll according to the method (6).
When digested with [, all plasmids were excised at one point each, resulting in a single band of approximately 7.6 Kb.
また、EcoRI消化により約5.9Kbのバンドおよ
びpIcT113のEcoRI−EcoRI断片と同じ
約1.7Kbのバンドを生じた。Ec。Additionally, EcoRI digestion produced a band of about 5.9 Kb and a band of about 1.7 Kb, which is the same as the EcoRI-EcoRI fragment of pIcT113. Ec.
R1,5aclのダブル消化では、上記的1.7Kbの
バンド、plcR113のEcoRI−3acl断片と
同じ約1.9Kbのバンド、および約4゜IKbのバン
ドを生じた。Double digestion of R1,5 acl yielded the 1.7 Kb band described above, a ˜1.9 Kb band identical to the EcoRI-3 acl fragment of plcR113, and a ˜4° I Kb band.
反L11 、Hi n d 1Mのダブル消化では、p
lcRTIIIのK」シJ、I 、Hl n d II
!消化物と同じ約6.2Kbのバンド、およびpIcD
112の旦coRV−H1ndl[断片と同じ約1.4
Kbのバンドを生じた。In double digestion of anti-L11, Hin d 1M, p
K of lcRTIII
! Approximately 6.2 Kb band same as the digest, and pIcD
112 coRV-H1ndl [approximately 1.4
A band of Kb was generated.
以上のことから、これらのプラスミドは、PICRTI
IIのHi ndll−3ma I 、断片とpICD
112のEcoRV−HinduIIr片断とが結合し
たものであることが分かった。From the above, these plasmids are PICRTI
Hindll-3ma I of II, fragment and pICD
It was found that 112 EcoRV-HinduIIr fragments were combined.
このプラスミドをpIcDRTlllとした。This plasmid was named pIcDRTlll.
即ち、得られたプラスミドp ICDRTI 11はA
laRをコードする遺伝子、D−ATAをコードする遺
伝子およびA1 aDHをコードする遺伝子を有するプ
ラスミドである。That is, the obtained plasmid p ICDRTI 11 is A
This is a plasmid containing a gene encoding laR, a gene encoding D-ATA, and a gene encoding A1 aDH.
(22)p ICDRTI 11を含むエシェリヒア・
コリ;エシェリヒア・コリHBIOI (pICDRT
III)の創製および該菌体からの酵素液の採取
ジャーナル・オブ・モレキュラー・バイオロジー (J
、 Mat、 Biol、) 、録、 159−162
(1970)に記載の方法に従って、0℃付近で塩化カ
ルシウム処理したエシェリヒア・コリHBIOIをプラ
スミドp ICDRTI 11と接触させることによっ
て形質転換した。(22) Escherichia including p ICDRTI 11
coli; Escherichia coli HBOI (pICDRT
III) Creation and collection of enzyme solution from the bacterial cells Journal of Molecular Biology (J
, Mat, Biol,), Record, 159-162
(1970), calcium chloride-treated Escherichia coli HBIOI was transformed by contacting with plasmid p ICDRTI 11 at around 0°C.
次に菌株をアンピシリン含有(5g/100m1)YT
培地750 mlで37℃、−晩培養し、遠心分離によ
り菌体を回収した0回収した菌体2.2gを、10mM
リン酸カリウム緩衝液pH7゜2 、0.01%2−メ
ルカプトエタノール、50μM P L P 501
1に懸濁した。Next, strain YT containing ampicillin (5g/100ml)
Cultured in 750 ml of medium at 37°C for one night, and collected cells by centrifugation. 2.2 g of collected cells were diluted with 10 mM
Potassium phosphate buffer pH 7°2, 0.01% 2-mercaptoethanol, 50 μM PLP 501
1.
超音波により菌体を破砕した後、15,0OOruで2
0分間遠心分離して上滑を回収し、無細胞抽出液を調製
した゛。After crushing the bacterial cells with ultrasonic waves, 2
The supernatant was collected by centrifugation for 0 minutes, and a cell-free extract was prepared.
次に、得られた無細胞抽出液の酵素活性を以下の方法に
より測定した。Next, the enzyme activity of the obtained cell-free extract was measured by the following method.
−D−ATA活性の測定法−
(15)に示した方法による
一AlaR活性の測定法−
グリシン−KCI−KOHIli液(pH9,0)10
0 μnol 、 PLP50nmol、 D−アラニ
ン50μ11゜1 、 NAD” 2.5 μ1loI
、 A l aDH(バチルス・ステアロサーモフィ
ラスIF012550由来)10Uおよび酵素を含む1
mlの反応液を50℃でキュベツト中で反応させ、NA
DHの生成に由来する340nmにおける吸光度の増加
を測定した。尚、ここでIUは、この条件下1分間に1
μ1101のNADHの生成を触媒する酵素量とした。- Method for measuring D-ATA activity - Method for measuring AlaR activity by the method shown in (15) - Glycine-KCI-KOHIli solution (pH 9,0) 10
0 μnol, PLP50nmol, D-alanine 50μ11゜1, NAD” 2.5μ1loI
, Al aDH (from Bacillus stearothermophilus IF012550) 10U and enzyme 1
ml of the reaction solution was reacted in a cuvette at 50°C, and the NA
The increase in absorbance at 340 nm resulting from the production of DH was measured. Note that IU is 1 minute per minute under these conditions.
The amount of enzyme that catalyzes the production of NADH in μ1101 was taken as the amount.
−A1 aDH活性の測定法−
グリシン−KCI−KOHM衝液(pH10,7)10
0μm1G+ 、 L−アラニン50μmol 、 N
AD” 2゜5μ11ol 、および酵素を含む1ml
の反応液を50℃でキュベツト中で反応させ、NADH
の生成に由来する340nmにおける吸光度の増加を測
定した。-A1 Method for measuring aDH activity- Glycine-KCI-KOHM buffer solution (pH 10,7) 10
0μm1G+, L-alanine 50μmol, N
AD” 2゜5μ11ol and 1ml containing enzyme
The reaction solution was reacted in a cuvette at 50°C, and NADH
The increase in absorbance at 340 nm resulting from the production of was measured.
尚、ここでIUは、この条件下1分間に1μsolのN
ADHの生成を触媒する酵素量とした。Note that IU is 1 μsol of N per minute under these conditions.
This was defined as the amount of enzyme that catalyzes the production of ADH.
−MDI活性の測定法−
トリス−塩酸緩衝液(p H8,0) 50μsol
、 L−リンゴ酸20μlot 、 NAD” 2.5
μsol 、および酵素を含む1mlの反応液を30℃
でキュベツト中で反応させ、NADHの生成に由来する
340nmにおける吸光度の増加を測定した。尚、ここ
でIUは、この条件下1分間に1μsolのNADHの
生成を触媒する酵素量とした。-Measurement method of MDI activity- Tris-HCl buffer (pH 8,0) 50 μsol
, L-malic acid 20 μlot, NAD” 2.5
1 ml of the reaction solution containing μsol and enzyme was heated at 30°C.
The reaction was carried out in a cuvette, and the increase in absorbance at 340 nm resulting from the generation of NADH was measured. Note that IU here was defined as the amount of enzyme that catalyzes the production of 1 μsol of NADH in 1 minute under these conditions.
その結果、D−ATA活性は1040U / ml、A
laR活性は8G、 7U / ml、Al aDH活
性は106 U/ml、MDH活性は18.5LJ/m
lであった。As a result, D-ATA activity was 1040U/ml, A
laR activity is 8G, 7U/ml, Al aDH activity is 106 U/ml, MDH activity is 18.5LJ/m
It was l.
次にこの無細胞抽出液を50℃で30分間処理し、熱処
理酵素液を得た。Next, this cell-free extract was treated at 50°C for 30 minutes to obtain a heat-treated enzyme solution.
(23)得られた熱処理酵素液を用いたD−アスパラギ
ン酸の製造
次に、この熱処理酵素液10μm、し−リンゴ酸アンモ
ニウム緩衝液(p H8,0) 100μ+101 、
L−アラニン1μ1IOl 、 NAD” 0.1
、tclloI 、 PLP50n101を含む反応液
1mlを37℃で24時間反応させた。(23) Production of D-aspartic acid using the obtained heat-treated enzyme solution Next, 10 μm of this heat-treated enzyme solution, 100 μm of ammonium malate buffer (pH 8,0),
L-alanine 1μ1IOl, NAD” 0.1
, tclloI, and PLP50n101 were reacted at 37° C. for 24 hours.
反応終了後、アミノ酸分析計およびキラルパックWH(
ダイセル化学製)を用いた高速液体クロマトグラフィに
より、反応液中のD−アスパラギン酸の生成量を測定し
た。その結果、得られたD−アスパラギン酸は、28゜
7μsolであった。After the reaction is complete, use an amino acid analyzer and Chiral Pack WH (
The amount of D-aspartic acid produced in the reaction solution was measured by high performance liquid chromatography (manufactured by Daicel Chemical). As a result, the amount of D-aspartic acid obtained was 28°7 μsol.
実施例2
熱処理酵素液量を20μmに変えた他は、実施例1と同
様に反応を行なった。その結果、得られたD−アスパラ
ギン酸は、40.6μIIolであった。Example 2 The reaction was carried out in the same manner as in Example 1, except that the amount of heat-treated enzyme solution was changed to 20 μm. As a result, the amount of D-aspartic acid obtained was 40.6μIIol.
(発明の効果)
本発明により、経済的に優れた方法でD−アスパラギン
酸を製造することが可能になった。(Effects of the Invention) The present invention has made it possible to produce D-aspartic acid using an economically superior method.
また、エシェリヒア・コリHBIOI (pICDRT
III)を用いることによって、本発明の方法を非常に
簡潔に行なうことができる。In addition, Escherichia coli HBIOI (pICDRT
By using III), the method of the invention can be carried out very simply.
第1図は、プラスミドplcT111の制限酵素切断地
図である。
第2図は、プラスミドpIc7113の制限酵素切断地
図である。
特許出願人 ダイセル化学工業株式会社第 1 図
pIcTlllの制限酵素切断地図
筒 2 図
pIc7113の制限酵素切断地図
(Kb)FIG. 1 is a restriction enzyme cleavage map of plasmid plcT111. FIG. 2 is a restriction enzyme cleavage map of plasmid pIc7113. Patent applicant Daicel Chemical Industries, Ltd. Figure 1 Restriction enzyme cleavage map of pIcTlll Figure 2 Restriction enzyme cleavage map of pIc7113 (Kb)
Claims (1)
セマーゼ、およびD−アミノ酸トランスアミナーゼを共
役させることにより、微量のアラニンおよびNAD^+
の存在下、L−リンゴ酸とアンモニアからD−アスパラ
ギン酸を製造する方法By conjugating malate dehydrogenase, alanine dehydrogenase, alanine racemase, and D-amino acid transaminase, trace amounts of alanine and NAD^+
A method for producing D-aspartic acid from L-malic acid and ammonia in the presence of
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11355388A JPH01285193A (en) | 1988-05-12 | 1988-05-12 | Production of d-aspartic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11355388A JPH01285193A (en) | 1988-05-12 | 1988-05-12 | Production of d-aspartic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01285193A true JPH01285193A (en) | 1989-11-16 |
Family
ID=14615212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11355388A Pending JPH01285193A (en) | 1988-05-12 | 1988-05-12 | Production of d-aspartic acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01285193A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998014602A3 (en) * | 1996-09-30 | 1998-07-09 | Monsanto Co | Preparation of d-amino acids by direct fermentative means |
WO1998048030A1 (en) | 1997-04-23 | 1998-10-29 | Kaneka Corporation | Process for producing optically active amino compounds |
WO2004022764A3 (en) * | 2002-09-03 | 2004-10-21 | Degussa | Use of malate dehydrogenase for nadh regeneration |
CN103998418A (en) * | 2011-12-19 | 2014-08-20 | 巴斯夫欧洲公司 | Process for preparing racemic alpha-amino acids |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62205790A (en) * | 1986-03-07 | 1987-09-10 | Daicel Chem Ind Ltd | Production of d-amino acid |
-
1988
- 1988-05-12 JP JP11355388A patent/JPH01285193A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62205790A (en) * | 1986-03-07 | 1987-09-10 | Daicel Chem Ind Ltd | Production of d-amino acid |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998014602A3 (en) * | 1996-09-30 | 1998-07-09 | Monsanto Co | Preparation of d-amino acids by direct fermentative means |
JP2001505048A (en) * | 1996-09-30 | 2001-04-17 | エヌ・エス・シー・テクノロジーズ・エル・エル・シー | Preparation of D-amino acid by direct fermentation means |
WO1998048030A1 (en) | 1997-04-23 | 1998-10-29 | Kaneka Corporation | Process for producing optically active amino compounds |
WO2004022764A3 (en) * | 2002-09-03 | 2004-10-21 | Degussa | Use of malate dehydrogenase for nadh regeneration |
CN103998418A (en) * | 2011-12-19 | 2014-08-20 | 巴斯夫欧洲公司 | Process for preparing racemic alpha-amino acids |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0206460A2 (en) | L-phenylalanine dehydrogenase and use thereof | |
CA2426594A1 (en) | Production of .alpha.-hydroxy-carboxylic acids using a coupled enzyme system | |
US5120652A (en) | Substantially purified n-acyl-l-proline acylase from comamonas testosteroni dsm 5416 and alcaligenes denitrificans dsm 5417 | |
JPH01285193A (en) | Production of d-aspartic acid | |
JPS59198972A (en) | Microbiologically produced l-phenylalanine dehydrogenase, obtaining method thereof and production of l-alpha-amino- carboxylic acid | |
US5783428A (en) | Method of producing fumaric acid | |
Soda et al. | [222] Amino acid racemase (Pseudomonas striata) | |
US5219741A (en) | Method of making L-proline using an N-acyl-L-protine acylase | |
JP2843596B2 (en) | Process for producing novel D-amidase and D-α-alanine and / or L-α-alanine amide | |
JPH01285192A (en) | Production of d-alanine | |
Kato et al. | 3-Methylaspartate ammonia-lyase from a facultative anaerobe, strain YG-1002 | |
JPS6058068A (en) | Novel amine dehydrogenase and oxidation of amine using it | |
US5212069A (en) | Method of using N-acetyl-2,3-Didehydroleucine acylase for the preparation of D- or L-tryptophyl glycine, D- or L-tryptophyl-D-methionine or L-tryptophyl-D-cysteine | |
US5134073A (en) | Microbiologically produced n-acetyl-2,3-didehydroleucine acylase | |
JPH0722510B2 (en) | Gene encoding thermostable tryptophan synthase and its use | |
JP2680665B2 (en) | Putrescine: Pyruvate transaminase | |
JP4231709B2 (en) | Novel dehydrogenase and gene encoding the same | |
JP2680686B2 (en) | Method for producing putrescine: pyruvate transaminase | |
JPS62244386A (en) | Production of l-amino acid | |
JPH0655137B2 (en) | L-phenylalanine dehydrogenase and method for producing the same | |
JPH02171193A (en) | Production of d-alanine | |
JPS62134094A (en) | Method for producing L-tryptophan by enzymatic method | |
JPS6244181A (en) | Heat-resistant aminoacylase sk-1 and production thereof | |
JPH0630572B2 (en) | L-phenylalanine dehydrogenase | |
JPS6033475B2 (en) | Immobilized aminoacylase enzyme and method for producing the same |